- 294 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
About this book
Anti-angiogenic Drugs as Chemosensitizers in Cancer Therapy, Volume 19Ā focuses on the use of anti-angiogenic drugs as sensitizers of tumor cells to the inhibitory activity of antitumor agents. Conventional and novel anti-neoplastic agents (cytotoxic molecules, hormones/antihormones, immunotherapies) are taken into consideration, along with advances made in combination therapies. The book encompasses examples of studies on the use of antiangiogenic compoundsāmolecules that inhibit the growth of vessels inside a tumorātogether with antineoplastic drugs in order to sensitize the resistant tumor to their cytotoxic effects, thus reducing adverse side reactions and resistance and improving the therapeutic response of cancer patients.
In addition, the book discusses clinical applications in various types of cancer, such as colorectal, lung, breast, renal, genitourinary, skin and brain and circulating tumors. It is a valuable resource for cancer researchers, clinicians and members of the biomedical field who wants to be up-to-date on the most recent and promising developments in the field.
- Provides the most updated reviews on anti-angiogenic drugs as chemosensitizers by leaders in the field
- Encompasses summarized tables and schematic diagrams in each chapter to give a clear overview on recent findings in a didactic manner
- Brings not only relevant information of current research but also new ideas and suggestions for further investigations to help advance the field
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weāve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere ā even offline. Perfect for commutes or when youāre on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy by in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover
- Front Matter
- Table of Contents
- Copyright
- Dedication
- Cover Image Insert
- Aims and Scope for Series āCancer Sensitizing Agents for Chemotherapyā
- About the Series Editor
- Aims and Scope of the Volume
- About the Volume Editor
- Preface
- Contributors
- List of Illustrations
- List of Tables
- Chapter 1 : Introduction: How tumor-endothelial cell communication within the tumor microenvironment affects angiogenesis
- Chapter 2 : Antiangiogenic drugs: Chemosensitizers for combination cancer therapy
- Chapter 3 : Antiangiogenic agents in the treatment of colorectal, gastric, and gastroesophageal junction adenocarcinoma
- Chapter 4 : Antiangiogenic drugs as chemosensitizer in renal cell cancer
- Chapter 5 : Antiangiogenic drugs as chemosensitizer in genitourinary cancer
- Chapter 6 : Antiangiogenic drugs as chemosensitizer in melanoma
- Chapter 7 : Antiangiogenic drugs as chemosensitizers in hematological tumors
- Chapter 8 : Metronomic chemotherapy and antiangiogenic drugs: Preclinical and clinical data
- Chapter 9 : Resistance to antiangiogenic treatments: A review
- Chapter 10 : Predictive āomicā biomarkers of drug response: Colorectal cancer as a model
- Chapter 11 : General conclusions and future perspectives
- Index
- A